ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,903Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 917

$470K Total Retail Price of All Prescriptions

Rank: 133 out of 917

605 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 605 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 605 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 10,089 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 580 539 1 2
LISINOPRIL 571 523 2 1
OMEPRAZOLE 494 399 3 4
LEVOTHYROXINE SODIUM 466 418 4 3
POTASSIUM CHLORIDE 439 376 5 16
AMLODIPINE BESYLATE 434 407 6 5
GABAPENTIN 386 289 7 17
CITALOPRAM HBR 347 295 8 15
FUROSEMIDE 323 279 9 7
HYDROCODONE-ACETAMINOPHEN 286 217 S3 10 6
METFORMIN HCL 279 243 11 8
METOPROLOL TARTRATE 275 259 12 11
HYDROCHLOROTHIAZIDE 274 233 13 9
LOSARTAN POTASSIUM 239 231 14 13
TRAMADOL HCL 170 154 15 28
ATORVASTATIN CALCIUM 164 143 16 14
ATENOLOL 150 126 17 12
DIGOXIN 148 148 18 41
PRAVASTATIN SODIUM 140 115 19 20
GLYBURIDE 126 125 R 20 71
TRAZODONE HCL 124 93 21 22
RANITIDINE HCL 124 104 21 29
LANTUS 113 105 23 37
LOVASTATIN 113 106 23 19
METHOCARBAMOL 106 57 R 25 87
METOPROLOL SUCCINATE 99 90 26 18
GLIMEPIRIDE 97 70 27 54
TRIAMTERENE-HCTZ 87 87 28 36
DIOVAN 79 79 29 49
SPIRIVA 77 77 30 45
ALENDRONATE SODIUM 73 73 31 23
OXYCODONE HCL 68 28 S2 32 27
TAMSULOSIN HCL 67 61 33 25
PAROXETINE HCL 65 65 34 57
ISOSORBIDE MONONITRATE ER 63 63 35 70
FLUTICASONE PROPIONATE 61 48 36 26
PREDNISONE 61 51 36 34
INSULIN SYRINGE 60 56 38 83
OXYBUTYNIN CHLORIDE 59 59 39 76
SERTRALINE HCL 58 43 40 24
ENALAPRIL MALEATE 57 57 41 79
CARVEDILOL 56 56 42 33
KLOR-CON M20 55 41 43 121
ALLOPURINOL 52 46 44 31
METHADONE HCL 52 16 S2 44 59
OXYCODONE-ACETAMINOPHEN 52 38 S2 44 46
LANTUS SOLOSTAR 50 43 47 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.